The groundbreaking therapy of the medication represents a major breakthrough in the handling of diabetes mellitus type 2. Unlike existing therapies, tirzepatide targets two pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide685523.mpeblog.com/76220906/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment